AstraZeneca has opened a plant to produce biogas from organic waste that will ensure by the end of this year all of its ...
The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and ...
Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...
KBP Biosciences Pte. Ltd. (the 'Company') today issued a statement addressing a recent decision by the Singapore International Commercial Court ('SICC'), which granted an injunction sought by Novo ...
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
14h
Irish Examiner on MSNOn the rebound: What are the long-term risks of Ozempic?Ahead of World Obesity Day, we examine the impact of the game-changing drugs that control appetite. Increasingly being taken ...
Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a ...
Hosted on MSN23h
What possible compounded semaglutide ban means for patientsThe FDA declared the shortage of Novo Nordisk's weight-loss drugs over, giving compounders until May to stop making alternatives. An industry group representing compounders is suing. Dr. Angela Fitch ...
Patient advocacy group Patients for Affordable Drugs (P4AD) yesterday filed its fourth amicus brief defending the Biden ...
New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...
We thank our colleagues for their interest in our Article.1 We agree with Zaoqu Liu and colleagues that in addition to mortality assessment, quality of life and long-term functional outcomes are ...
Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results